Peter M. Krein

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Eli Lilly (United States)(Current)

Loxo Oncology at Lilly (United States)

Peter M. Krein is an author at Eli Lilly (United States) specializing in biomarkers for metastatic disease, biomarker-guided therapy selection, and oncology.

Publications per year

2022–2023

Publications

Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021

Lisa M. Hess, Peter M. Krein, Diane Haldane et al. · JTO Clinical and Research Reports · 2022 · 38 citations · Full text

Medicine, Oncology, Molecular Diagnostics +12

Real-World Biomarker Testing Patterns in Patients With Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in a US Community-Based Oncology Practice Setting

Anthony Sireci, Peter M. Krein, Lisa M. Hess et al. · Clinical Lung Cancer · 2023 · 15 citations

Medicine, Oncology, Medical Oncology +11

1–2 of 2